The iconic Calder’s Flamingo in Federal Plaza, in the Loop. Tyler Pasciak LaRiviere/Sun-Times Share Chicago’s Federal Center — two minimalist steel-and-glass towers, a 50-foot sculpture ...

Follow Bloomberg India on WhatsApp for exclusive content and analysis on what billionaires, businesses and markets are doing. Sign up here. Eli Lilly and Co. has begun selling its blockbuster ...

A Florida circuit judge on Monday denied the Pulitzer Board’s request to pause a defamation lawsuit from Donald Trump until the president is out of office. The decision from the 19th Judicial ...

It's very much my pleasure to welcome members of Lilly's leadership team to be here with us in Miami, and thank you for making the trip. So, to my right is Lucas Montarce who is the company's CFO ...

That negative investor reaction was directed at companies involved in the white-hot weight loss drug segment of the market (Eli Lilly is the pharmaceutical giant behind a popular one, Zepbound).

March 10 (Reuters) - Eli Lilly (LLY.N), opens new tab plans to launch its blockbuster diabetes and weight-loss drug in major emerging markets like India, Brazil and Mexico in the second half of ...

Earlier this week, Eli Lilly partnered up with telehealth providers LifeMD and Teladoc Health to offer its lower cost, single-vial Zepbound (tirzepatide) to patients in the virtual care companies ...

A federal court in Texas has rejected a request by producers of compounded drugs to extend their ability to manufacture knockoff versions of Eli Lilly's tirzepatide while a lawsuit plays out.

Eli Lilly (LLY) ended the recent trading session at $912.76, demonstrating a -1.82% swing from the preceding day's closing price. The stock's performance was behind the S&P 500's daily loss of 1.78%.

Small compounding pharmacies must halt selling copies immediately, larger facilities by March 19 Compounders argue FDA relied on Lilly for shortage figures Separate lawsuit by compounders over ...